1David I. Schwartz,Noralane M. Lindor,Cate Walsh-Vockley,Patrick C. Roche,Ming Mai,David I. Smith,Wanguo Liu,Fergus J. Couch. p73 mutations are not detected in sporadic and hereditary breast cancer[J] 1999,Breast Cancer Research and Treatment(1):25～29
2M. Reichelt,K. D. Zang,M. Seifert,C. Welter,T. Ruffing. The yeast two-hybrid system reveals no interaction between p73α and SV40 large T-antigen[J] 1999,Archives of Virology(3):621～626
3Nakagawa T, Takahashi M, Ozaki T, et al. Autoinhibitory regulation of p73 by ΔNp73αto modulate cell survival and death through a p73-specific target element within the ΔNp73αpromoter[J]. Mol Cell Biol, 2002,22(8): 2575
4Zaika AI, Slade N, Erster SH, et al. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors[J] .J Exp Med, 2002,196(6):765
5Alonso M. Mutation analysis of the p73 gene in nonastrocytic brain tumours[J]. Br J Cancer,2001,85(2):204
6Zemel R, Koren C, Bachmatove L, et al. p73 overexpression and nuclear accumulation in hepatitis C virus-associated hepatocellular carcinoma[J]. Dig Dis Sci,2002,47(4): 716
7Ueda Y, Hijikata M, Takagi S, et al. Transcriptional activities of p73 splicing variants are regulated by inter-variant association[J]. Biochemistry J,2001,356(3):859
8Casciano I, Mazzocco K, Boni L, et al. Expression of ΔNp73αis a molecular marker for adverse outcome in neuroblastoma patients[J]. Cell Death Differ,2002,9(3): 246
